To the Editor:

The novel coronavirus SARS-CoV2 is causing a global pandemic. The syndrome associated with the infection, COVID-19, encompasses fever, coughing, dyspnea and severe pneumonia with respiratory failure \[[@bb0005]\]. Severity of structural lung involvement appears not to be the only factor contributing to respiratory failure and respiratory failure in COVID-19 appears to be characterized by a dissociation between well-preserved lung mechanics and severity of hypoxemia \[[@bb0010]\]. These observations suggest that additional factors beyond direct pulmonary damage might play a role in the most critical cases.

Brainstem involvement has been proposed as a possible cause of respiratory failure in SARS-CoV-2 infection, given that the virus appears to have potential for inducing neurological damage, a number of neurological symptoms have been described, and SARS-CoV has been reported to massively infect the brainstem in both patients and experimental animals \[[@bb0015]\]. Of relevance, a retrospective study on moderately to critically ill COVID-19-patients found that 22% of the patients who died showed disorders of consciousness at admission compared to 1% of the recovered patients \[[@bb0005]\]. In addition, autoimmune neurological complications of SARS-CoV-2 have already been reported \[[@bb0020],[@bb0025]\]. Moreover, COVID-19 appears to be associated with hyper-activation of the immune system and cytokine storm thus resembling other clinical conditions characterized by immune dysregulation \[[@bb0030],[@bb0035]\]. Cytokine storm is a possible pathogenic mechanism of the acute necrotizing encephalopathy reported in COVID-19 \[[@bb0035],[@bb0040]\].

In light of the above, damage to the respiratory pacemaker in the brainstem, also known as pre-Bötzinger complex (preBötC) \[[@bb0045]\], might contribute to respiratory failure in COVID-19 as a consequence of mimicry between viral and neuronal proteins of the preBötC. Indeed, the proteome of the virus (<https://www.ncbi.nlm.nih.gov/nuccore/MN908947>) shares three sequences of six amino acids (GSQASS, LNEVAK, and SAAEAS) with three proteins, namely DAB1, AIFM, and SURF1 (as catalogued at [www.uniprot.org](http://www.uniprot.org){#ir0025}) that are present in the human brainstem preBötC ([Table 1](#t0005){ref-type="table"} ) and are part of experimentally validated epitopes \[[@bb0050]\]. Interestingly, the three sequences are absent in other human Coronaviruses (hCoV-HKU-1 and hCoV-OC-43) that can cause lung damage but are not typically associated with respiratory failure \[[@bb0055]\].Table 1Hexapeptides of immunologic relevance shared between SARS-CoV-2 and proteins related to the preBötC. The experimentally validated immunogenic epitopes containing the shared motifs are presented in the last column.Table 1Shared 6-merSARS-CoV-2 proteinHuman protein \[UniProt-ID\]Epitopes \[IEDB-ID; Protein; Organism\]GSQASSnucleocapsid\
phosphoproteinDAB1\
Disabled homolog 1\
\[[O75553](uniprotkb:O75553){#ir0005}\]PKGFYAEGSRG**GSQASS**R\
\[48067; Nucleoprotein; SARS-CoV\]\
SRG**GSQASS**RSSSRSR\
\[60669; Nucleoprotein; SARS-CoV\]LNEVAKsurface\
glycoproteinAIFM1\
Apoptosis-inducing factor 1,\
mitochondrial\
\[[O95831](uniprotkb:O95831){#ir0010}\]R**LNEVAK**NL\
\[54680; Spike glycoprotein; SARS-CoV\]\
EIDR**LNEVAK**NLNESLIDLQELGKYEQY + ACET(E1)\
\[12426; Spike glycoprotein; SARS-CoV\]\
EIDR**LNEVAK**NLNESLIDLQELGKYEQY\
\[558417; Spike glycoprotein; SARS-CoV\]SAAEASnucleocapsid\
phosphoproteinSURF1\
Surfeit locus protein 1\
\[[Q15526](uniprotkb:Q15526){#ir0015}\]KK**SAAEAS**KKPRQKRTA\
\[31692; Nucleoprotein; SARS-CoV\]\
KK**SAAEAS**KKPRQKRTATKQYNVTQ\
\[31693; Nucleoprotein; SARS-CoV\]\
QQQGQTVTKK**SAAEAS**KK\
\[52117; Nucleoprotein; SARS-CoV\]

DAB1 belongs to the Reelin signalling pathway \[[@bb0060]\]. Three main points bear relevance for the potential involvement of DAB1 in preBötC-dysfunction and respiratory failure:-DAB1-mutant mice show the same phenotype as Reelin-mutants, and both proteins need to be concurrently expressed in humans for the signal pathway to function properly \[[@bb0060]\].-Reelin is a specific marker of preBötc neurons \[[@bb0045]\].-Reelin-mutations are associated with impaired response to hypoxia \[[@bb0045]\].

AIFM1 and SURF1 are involved in mitochondrial metabolism and, when altered as consequence of mutations, cause Leigh syndrome \[[@bb0065]\]. Of relevance for the present hypothesis, death in Leigh syndrome results most often from respiratory failure and, crucially, mouse models of the disease show pathological functioning of the preBötC \[[@bb0070]\]. Leigh syndrome is indeed the eponym of a subacute necrotizing encephalopathy that closely resembles morphologically the acute necrotizing encephalopathy associated with COVID-19 \[[@bb0075]\].

In the context of this peptide sharing between the preBötc, and SARS-CoV-2, it appears possible that immunological targeting of DAB1, AIFM1, and SURF1 might contribute to brainstem-related respiratory failure in COVID-19 patients and that a therapeutic benefit might come from immunomodulatory agents. To test this hypothesis, sera and cerebrospinal fluid from COVID-19 patients suffering from respiratory distress and/or neurological symptoms might be examined for immunoreactivity against the shared protein sequences. Evidence of causality can be obtained from animal models by immunizing the individuals with the same protein sequences.
